Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. US /
  3. EYEG.US

AB Corporate Bond ETF (EYEG NASDAQ) stock market data APIs

35.76 0(0%) as of July 26, 2024

AB Corporate Bond ETF Financial Data Overview

35.76
35.76
127
35.79
35.76
0 - 0
24673546
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

Get AB Corporate Bond ETF Earnings via APIs

  • Latest Release NaN
  • EPS/Forecast NaN

Get AB Corporate Bond ETF End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get AB Corporate Bond ETF latest news via APIs

EyeGate is Now Kiora Pharmaceuticals; Provides Update on Company’s Sharpened Clinical Development Strategy

SALT LAKE CITY, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), (“Kiora” or the “Company”) is the new name of EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG). Kiora will trade on the Nasdaq Capital Market under the ticker symbol "KPRX" and CUSIP number 49721T101....
  • COMPANY ANNOUNCEMENT
  • HEALTH
  • INC
  • KIORA PHARMACEUTICALS
  • NASDAQ:KPRX

EyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc.

WALTHAM, Mass., Oct. 26, 2021 (GLOBE NEWSWIRE) -- EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG), (“EyeGate” or the “Company”), a clinical stage specialty pharmaceutical company developing and commercializing products for treating ophthalmic diseases, today announced that it has completed th...
  • DIRECTORS AND OFFICERS
  • EYEGATE PHARMACEUTICALS
  • INC
  • NASDAQ:EYEG
Do you have any questions?
support@eodhistoricaldata.com